ANEBULO PHARMACEUTICALS
Anebulo is a clinical-stage biotechnology company developing novel solutions for people suffering from cannabinoid overdose and substance addiction. Its lead product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within one hour of administration. Clinical trials completed to date have shown that ANEB-001 is rapidly absorbed, well-tolerated, and leads to weight loss, an effect that is consistent with central cannabinoid receptor type 1 antagonism.
ANEBULO PHARMACEUTICALS
Industry:
Biotechnology Life Science MHealth
Founded:
2020-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.anebulo.com
Total Employee:
1+
Status:
Active
Contact:
512-598-0931
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Ataxion
Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Current Employees Featured
Founder
Stock Details
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-04 | Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director |
Official Site Inspections
http://www.anebulo.com Semrush global rank: 4.38 M Semrush visits lastest month: 2.56 K
- Host name: box2005.bluehost.com
- IP address: 74.220.219.155
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Anebulo Pharmaceuticals"
About Us – Anebulo Pharmaceuticals
Anebulo was founded with the intention of developing disruptive treatments for substance use disorders, such as cannabinoid intoxication and the broader addiction landscape We …See details»
Anebulo Pharmaceuticals
– Anebulo Pharmaceuticals prioritizes development of Selonabant for unintentional cannabis poisoning in children in response to the growing need and impending change in DEA …See details»
Corporate Governance :: Anebulo Pharmaceuticals, Inc. (ANEB)
Calloway is the lead for 22NW, LP’s biotechnology, pharmaceutical and other healthcare investments, including Anebulo Pharmaceuticals, Inc. Prior to that, Dr. Calloway was the …See details»
Anebulo Pharmaceuticals - Crunchbase Company …
Organization. Anebulo Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
Investor Relations :: Anebulo Pharmaceuticals, Inc. (ANEB)
Nov 13, 2024 Anebulo Pharmaceuticals, Inc. 1017 Ranch Road 620 South Suite 107 Lakeway, TX 78734 T: 512-598-0931 [email protected]. Transfer Agent. Continental Stock Transfer & Trust Company 17 Battery Place 8th Floor New …See details»
News & Events :: Anebulo Pharmaceuticals, Inc. (ANEB)
Dec 23, 2024 Anebulo Pharmaceuticals 1017 Ranch Road 620 South Suite 107 Lakeway, TX 78734 Phone: 512-598-0931 Email: [email protected]See details»
Management Presentation April 2021 - Anebulo
Apr 26, 2021 Anebulo Pharmaceuticals, Inc. (the “Company”) has filed a registration statement on Form S-1 (including a prospectus, which currently is in preliminary ... marketing …See details»
Anebulo Pharmaceuticals - Org Chart, Teams, Culture & Jobs - The …
Anebulo was founded with the intention of developing disruptive treatments for substance use disorders, such as cannabinoid intoxication and the broader addiction landscape. Industries. …See details»
Anebulo Pharmaceuticals (ANEB) Company Profile & Description
May 7, 2021 Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, …See details»
Anebulo Pharmaceuticals - LinkedIn
Anebulo Pharmaceuticals | 142 followers on LinkedIn. Anebulo is developing innovative therapies that will improve the lives of patients suffering from acute cannabinoid intoxication and substance ...See details»
Anebulo Pharmaceuticals - Funding, Financials, Valuation & Investors
Anebulo Pharmaceuticals is registered under the ticker NASDAQ:ANEB . Their stock opened with $7.00 in its May 6, 2021 IPO. Stock Symbol NASDAQ:ANEB ; Valuation at IPO $162.9M; …See details»
Anebulo Pharmaceuticals
Feb 25, 2025 Anebulo Pharmaceuticals was founded in Spain in 1982 and has since become a multinational enterprise, operating in 25 countries across Europe, Latin America, Africa and …See details»
Pipeline – Anebulo Pharmaceuticals
Anebulo at a Glance We are a clinical stage biotech company developing novel solutions to help people suffering from acute cannabinoid toxicity. Our lead product candidate is an antidote to …See details»
Anebulo Pharmaceuticals Names Biotechnology Industry Executive …
Jan 4, 2022 Anebulo Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and …See details»
Anebulo Pharmaceuticals - Contacts, Employees, Board Members, …
Anebulo is a biotech company developing novel solutions for people suffering from cannabinoid overdose and substance addiction. ... Experience the new Crunchbase, powered by AI . …See details»
Anebulo Pharmaceuticals Inc. - Cruelty Free Investing
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The …See details»
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 ...
14 hours ago AUSTIN, Texas--(BUSINESS WIRE)-- Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people …See details»
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 ...
10 hours ago AUSTIN, Texas--(BUSINESS WIRE)--Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people …See details»
Anebulo Pharmaceuticals Reports Recent Business Highlights and ...
Jun 21, 2021 Anebulo remains on track to commence a Phase 2 proof-of-concept clinical trial with ANEB-001 for the treatment of cannabinoid overdose in the fourth quarter of 2021 with …See details»
Anebulo Pharmaceuticals: 10 Key Things You Must Know
Anebulo Pharmaceuticals, cannabinoid intoxication, selonabant, pharmaceutical industry, acute cannabis intoxication, pediatric cannabis toxicity, drug development, biopharmaceutical …See details»